Erectile Dysfunction (ED) Drugs Market – Overview
This report studies the current as well as future prospects of the global erectile dysfunction (ED) drugs market. Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and marketing of therapeutic drugs for the treatment of erectile dysfunction, as well as new players planning to enter the market. The report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. The section also provides overall information and data analysis of the global erectile dysfunction drugs market with respect to the leading segments based on drug class, distribution channel, and region.
The global erectile dysfunction drugs market has been segmented based on drug, distribution channel, and region. In terms of drug, the market has been classified into Viagra, Cialis, Staxyn/Levitra, Stendra/Spedra, and others. Based on distribution channel, the global erectile dysfunction drugs market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
Request Brochure for Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1550
Global Erectile Dysfunction (ED) Drugs Market: Snapshot
The increasing prevalence of erectile dysfunction is boosting the global erectile dysfunction (ED) market. Erectile dysfunction can be caused due to various factors such as aging, cardiovascular diseases, spinal cord injuries, hypertension, side-effects of medicines consumed, and others. The effective and first line of treatment for ED comprises the oral medication such as Oral phosphodiesterase type 5 (PDE5) inhibitor.Male sexual abilities decreases post 50 years of age coupled with rising incidence of ED. The elderly population is susceptible to the erectile dysfunction which is boosting the need for novel drugs for the treatment of this incapability. Moreover, some psychological and physical changes, coupled with growing incidences of hormonal alteration, are leading to increasing the erectile dysfunction which is propelling growth of the global erectile dysfunction (ED) drugs market.
A study by New England Research Institutes, the patients suffering from erectile dysfunction was 152 million in 1995 and is expected to increase to 322 million in 2025. This rise in cases of erectile dysfunction is due to the growing geriatric population. This growing number is creating the need for the novel treatments and likely to propel the growth of the erectile dysfunction (ED) drugs market.
According to the TMR, the global erectile dysfunction (ED) drugs market was valued at US$4.35 Bn in 2016 and is expected to decline with 3.2% CAGR over the forecast period from 2018 to 2026 to reach a value of US$ 2.87 Bn by the end of 2026.
Request for Analysis of COVID19 Impact on Erectile Dysfunction (ED) Drugs Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1550
Growth Witnessed in Retail Segment to Boost Market
On the basis of the drug, the global erectile dysfunction (ED) drugs market is segmented into viagra, cialis, staxyn/levitra, and stendra/spedra. Of these, cialis (tadalafil) dominated the global market for erectile dysfunction (ED) drugs followed by Viagra. Viagra segment was dominating the market, however, patent expiry affected its business. Additionally, patent expiry of Cialis in 2017 affected the growth of the market drastically.
On the basis of the distribution channel, the global erectile dysfunction (ED) drugs market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Of these, the retail pharmacies segment is expected to dominate the global erectile dysfunction (ED) drugs market owing to its easy availability of erectile dysfunction drugs at retail stores. The hospital pharmacies segments are accounting for the second-leading share and expected to expand with higher CAGR over the forecast period.
Key Players of Erectile Dysfunction (ED) Drugs Market Report:
Some of the key players operating in the erectile dysfunction (ED) drugs market are Pfizer, Inc., Eli Lilly and Company, Dong-A ST Co., Ltd., VIVUS, INC., and Bayer AG. The global erectile dysfunction (ED) drugs market has consolidated vendor landscape. The aforementioned players are accounting for major shares in the global market for erectile dysfunction (ED) drugs. These manufacturers are increasingly launching new products in the international market to fulfill the unmet demands from patients for the treatment of erectile dysfunction.
Buy Erectile Dysfunction (ED) Drugs Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=1550<ype=S
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
